Prolonged immunosuppression after CD34(+) or CD34(+)/Thy-1(+)/Lin(*) selected autologous peripheral blood stem cell (PBSC) transplants (Tx) for multiple myeloma

被引:0
|
作者
Siegel, D [1 ]
Mehta, J [1 ]
Anaissie, E [1 ]
Desikan, KR [1 ]
Fassas, A [1 ]
Jagannath, S [1 ]
Singhal, S [1 ]
Tricot, G [1 ]
Munshi, N [1 ]
Barnhart, S [1 ]
Hood, S [1 ]
Spoon, D [1 ]
Mattox, S [1 ]
Barlogie, B [1 ]
机构
[1] UNIV ARKANSAS MED SCI,LITTLE ROCK,AR 72205
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:487 / 487
页数:1
相关论文
共 50 条
  • [21] Outcome following CD34 selected allogeneic stem cell transplantation for patients with multiple myeloma
    Guillaume, H
    Moreau, P
    Delaunay, J
    Vigouroux, S
    Chevallier, P
    Mahé, B
    Le Gouill, S
    Dubruille, V
    Morineau, N
    Gastine, T
    Bercegay, S
    Saiag, S
    Saulquin, B
    Harousseau, JL
    Milpied, N
    BONE MARROW TRANSPLANTATION, 2006, 37 : S141 - S142
  • [22] CD34 selections from myeloma peripheral blood cell autografts contain residual tumour cells due to impurity, not to CD34(+) myeloma cells
    Willems, P
    Croockewit, A
    Raymakers, R
    Holdrinet, R
    VanderBosch, G
    Huys, E
    Mensink, E
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (03) : 613 - 622
  • [23] Preferential mobilization and yield of normal donor primitive CD34(+) Thy-1(dim) and CD34(+) Thy-1(dim) CD38(-) progenitor cells and lymphoid subsets for allogeneic blood stem cell transplantation: Possible predictors of clinical outcome
    Korbling, M
    Durett, A
    Huh, YO
    Mirza, N
    Anderlini, P
    Seong, D
    Przepiorka, D
    Deisseroth, A
    Champlin, R
    BLOOD, 1995, 86 (10) : 414 - 414
  • [24] Hematopoietic stem cell (HSC) transplantation in multiple myeloma with selected autologous peripheral blood CD34+THY-1+ cells.
    Michallet, M
    Philip, I
    Coiffier, B
    Salles, G
    Sebban, C
    Godinot, H
    Roubi, N
    Lopez, F
    Bessueille, L
    Mazars, P
    Gerard, C
    Hanania, E
    Ramanathan, R
    Reading, C
    Juttner, C
    Atkinson, K
    Fière, D
    Philip, T
    Archimbaud, E
    BLOOD, 1998, 92 (10) : 728A - 728A
  • [25] Selected autologous peripheral blood CD34+ Thy-1+ Lin- hematopoietic stem cell (HSC) transplantation in multiple myeloma: A European study.
    Archimbaud, E
    Philip, I
    Coiffier, B
    Michallet, M
    Salles, G
    Sebban, C
    Roubi, N
    Lopez, F
    Bessueille, L
    Mazars, P
    Gerard, C
    Hanania, S
    Ramanathan, R
    Reading, C
    Juttner, C
    Atkinson, K
    Philip, T
    BLOOD, 1997, 90 (10) : 1754 - 1754
  • [26] OPTIMIZING FACTORS FOR HEMATOLOGICAL RECOVERY AFTER AUTOLOGOUS CD34 POSITIVE PERIPHERAL-BLOOD STEM-CELLS (PBSC) TRANSPLANTATION
    SADOUN, A
    DEBOUCHONY, ET
    GIRAUD, C
    DREYFUS, B
    RANDRIAMALALA, F
    BRIZARD, A
    ALCALAY, D
    GUILHOT, F
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 756 - 756
  • [27] Autologous CD34 positive peripheral blood stem cell (PBSC) transplantation for acute promyelocytic leukemia (APL): Report of a case.
    Veinstein, A
    Sadoun, A
    Brizard, A
    Chomienne, C
    Guilhot, F
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 485 - 485
  • [28] CD34(+) cell subsets and platelet recovery after PBSC autograft
    Buscemi, F
    Indovina, A
    Scime, R
    Santoro, A
    Pampinella, M
    Fiandaca, T
    Caronia, F
    Majolino, I
    BONE MARROW TRANSPLANTATION, 1995, 16 (06) : 855 - 856
  • [29] Costs of autologous peripheral blood stem cell (PBSC) transplantation can be reduced by PB CD34 screening before apheresis.
    Areman, EM
    Rhodes, PL
    Meehan, KR
    Sacher, RA
    BLOOD, 1997, 90 (10) : 4198 - 4198
  • [30] The value of CD34 in monitoring peripheral blood stem cell harvests.
    Fleming, G
    Ford, A
    Mackie, M
    Blackstock, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 93 - 93